NEW DELHI: Roche India and Cipla stated the very first batch of antibody cocktail (Casirivimab and Imdevimab) is currently available in India, though a second batch is going to be made accessible by mid-June. The antibody cocktail is for limited use in emergency scenario for treating mild to medium Covid, particularly in patients that are at high risk of creating a serious ailment, ” says a company announcement.
Antibody cocktail Started in India
